Significance of serum CXCL10/IP-10 level in type 1 diabetes

This publication has 24 references indexed in Scilit:

• Physiological β Cell Death Triggers Priming of Self-reactive T Cells by Dendritic Cells in a Type-1 Diabetes Model
  The Journal of Experimental Medicine, 2003
• T-cell function in anti-GAD65+diabetes with residual β-cell function
  Journal of Autoimmunity, 2003
• Assessment of β Cell Mass and Oxidative Peritoneal Exudate Cells in Murine Type 1 Diabetes using Adoptive Transfer System
  Autoimmunity, 2003
• Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease
  Diabetologia, 2002
• Type 1 diabetes: new perspectives on disease pathogenesis and treatment
  The Lancet, 2001
• CXCL10 (IFN-γ-Inducible Protein-10) Control of Encephalitogenic CD4+ T Cell Accumulation in the Central Nervous System During Experimental Autoimmune Encephalomyelitis
  The Journal of Immunology, 2001
• Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions
  Neuropathology and Applied Neurobiology, 2000
• Chemokines — Chemotactic Cytokines That Mediate Inflammation
  New England Journal of Medicine, 1998
• Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice
  Diabetes, 1996
• The Murine Autoimmune Diabetes Model: NOD and Related Strains
  Published by Elsevier ,1992